Longitudinal Changes of MtDNA A3243G Mutation Load and Level of Functioning in MELAS

Overview

Journal Am J Med Genet A

Specialty Genetics

Date 2009 Mar 3

PMID 19253345

Citations 19

Authors

Mahsa Mehrazin

Sara Shanske

Petra Kaufmann

Ying Wei

Jorida Coku

Kristin Engelstad

Ali Naini

Darryl C De Vivo

Salvatore DiMauro

Affiliations

Soon will be listed here.

Abstract

Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS), one of the most common mitochondrial multisystemic diseases, is most commonly associated with an A-to-G transition at nucleotide position 3243 (A3243G) in mitochondrial DNA. We studied 34 individuals harboring the A3243G mutation for up to 7 years; 17 had the full MELAS phenotype and 17 who were classified as "carrier relatives" because they were either asymptomatic or had some symptoms suggestive of mitochondrial disease but no seizures or strokes. Using the sensitive real-time polymerase chain reaction to quantify the A3243G mutation, we confirmed that the percent mutation decreases progressively in DNA isolated from blood: the average percent decrease was 0.5% per year for fully symptomatic patients and 0.2% per year for oligosymptomatic carrier relatives. We also correlated mutant loads with functional status estimated by the Karnofksky score: even though the mutation load decreases, the level of functioning worsens in fully symptomatic patients, whereas the level of functioning of carrier relatives remains largely unchanged. This study suggests that A3243G mutant load in DNA isolated from blood is neither useful for prognosis nor for functional assessment.

Citing Articles

Mitochondrial point heteroplasmy: insights from deep-sequencing of human replicate samples.

Korolija M, Sukser V, Vlahovicek K BMC Genomics. 2024; 25(1):48.

PMID: 38200446 PMC: 10782721. DOI: 10.1186/s12864-024-09963-z.

The West of Scotland Cohort of Mitochondrial Individuals with the m.3243A>G Variant: Variations in Phenotypes and Predictors of Disease Severity.

Saunders C, Longman C, Gorman G, James K, Oliwa A, Petty R J Neuromuscul Dis. 2023; 11(1):179-189.

PMID: 38108361 PMC: 10789362. DOI: 10.3233/JND-230166.

Droplet digital polymerase chain reaction to measure heteroplasmic m.3243A>G mitochondrial mutations.

Matsumoto S, Uchiumi T, Noda N, Ueyanagi Y, Hotta T, Kang D Lab Med. 2023; 55(2):227-233.

PMID: 37478467 PMC: 10920975. DOI: 10.1093/labmed/lmad063.

Identification of peripheral vascular function measures and circulating biomarkers of mitochondrial function in patients with mitochondrial disease.

van Kraaij S, Pereira D, Smal B, Summo L, Konkel A, Lossie J Clin Transl Sci. 2023; 16(7):1258-1271.

PMID: 37177864 PMC: 10339694. DOI: 10.1111/cts.13530.

Dynamics of the most common pathogenic mtDNA variant m.3243A > G demonstrate frequency-dependency in blood and positive selection in the germline.

Franco M, Pickett S, Fleischmann Z, Khrapko M, Cote-LHeureux A, Aidlen D Hum Mol Genet. 2022; 31(23):4075-4086.

PMID: 35849052 PMC: 9703810. DOI: 10.1093/hmg/ddac149.

References

Goto Y, Nonaka I, Horai S . A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature. 1990; 348(6302):651-3. DOI: 10.1038/348651a0. View

Chinnery P, Howell N, Lightowlers R, Turnbull D . Molecular pathology of MELAS and MERRF. The relationship between mutation load and clinical phenotypes. Brain. 1997; 120 ( Pt 10):1713-21. DOI: 10.1093/brain/120.10.1713. View

Kobayashi Y, Momoi M, Tominaga K, Shimoizumi H, Nihei K, Yanagisawa M . Respiration-deficient cells are caused by a single point mutation in the mitochondrial tRNA-Leu (UUR) gene in mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS). Am J Hum Genet. 1991; 49(3):590-9. PMC: 1683152. View

Liolitsa D, Rahman S, Benton S, Carr L, Hanna M . Is the mitochondrial complex I ND5 gene a hot-spot for MELAS causing mutations?. Ann Neurol. 2003; 53(1):128-32. DOI: 10.1002/ana.10435. View

Rahman S, Poulton J, Marchington D, Suomalainen A . Decrease of 3243 A-->G mtDNA mutation from blood in MELAS syndrome: a longitudinal study. Am J Hum Genet. 2000; 68(1):238-40. PMC: 1234919. DOI: 10.1086/316930. View

Jeppesen T, Schwartz M, Frederiksen A, Wibrand F, Olsen D, Vissing J . Muscle phenotype and mutation load in 51 persons with the 3243A>G mitochondrial DNA mutation. Arch Neurol. 2006; 63(12):1701-6. DOI: 10.1001/archneur.63.12.1701. View

Sue C, Quigley A, Katsabanis S, Kapsa R, Crimmins D, Byrne E . Detection of MELAS A3243G point mutation in muscle, blood and hair follicles. J Neurol Sci. 1999; 161(1):36-9. DOI: 10.1016/s0022-510x(98)00179-8. View

Singh R, Ellard S, Hattersley A, Harries L . Rapid and sensitive real-time polymerase chain reaction method for detection and quantification of 3243A>G mitochondrial point mutation. J Mol Diagn. 2006; 8(2):225-30. PMC: 1867583. DOI: 10.2353/jmoldx.2006.050067. View

MacMillan C, Lach B, Shoubridge E . Variable distribution of mutant mitochondrial DNAs (tRNA(Leu[3243])) in tissues of symptomatic relatives with MELAS: the role of mitotic segregation. Neurology. 1993; 43(8):1586-90. DOI: 10.1212/wnl.43.8.1586. View

10.

King M, Koga Y, Davidson M, Schon E . Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNA(Leu(UUR)) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Mol Cell Biol. 1992; 12(2):480-90. PMC: 364194. DOI: 10.1128/mcb.12.2.480-490.1992. View

11.

Kirby D, Salemi R, Sugiana C, Ohtake A, Parry L, Bell K . NDUFS6 mutations are a novel cause of lethal neonatal mitochondrial complex I deficiency. J Clin Invest. 2004; 114(6):837-45. PMC: 516258. DOI: 10.1172/JCI20683. View

12.

DiMauro S, Schon E . Mitochondrial respiratory-chain diseases. N Engl J Med. 2003; 348(26):2656-68. DOI: 10.1056/NEJMra022567. View

13.

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

14.

Campos Y, Bautista J, Gutierrez-Rivas E, Chinchon D, Cabello A, Segura D . Clinical heterogeneity in two pedigrees with the 3243 bp tRNA(Leu(UUR)) mutation of mitochondrial DNA. Acta Neurol Scand. 1995; 91(1):62-5. DOI: 10.1111/j.1600-0404.1995.tb05845.x. View

15.

Ravn K, Wibrand F, Hansen F, Horn N, Rosenberg T, Schwartz M . An mtDNA mutation, 14453G-->A, in the NADH dehydrogenase subunit 6 associated with severe MELAS syndrome. Eur J Hum Genet. 2002; 9(10):805-9. DOI: 10.1038/sj.ejhg.5200712. View

16.

Holt I, Harding A, Petty R, Morgan-Hughes J . A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet. 1990; 46(3):428-33. PMC: 1683641. View

17.

Pyle A, Taylor R, Durham S, Deschauer M, Schaefer A, Samuels D . Depletion of mitochondrial DNA in leucocytes harbouring the 3243A->G mtDNA mutation. J Med Genet. 2006; 44(1):69-74. PMC: 2597915. DOI: 10.1136/jmg.2006.043109. View

18.

Shiraiwa N, Ishii A, Iwamoto H, Mizusawa H, Kagawa Y, Ohta S . Content of mutant mitochondrial DNA and organ dysfunction in a patient with a MELAS subgroup of mitochondrial encephalomyopathies. J Neurol Sci. 1993; 120(2):174-9. DOI: 10.1016/0022-510x(93)90270-9. View

19.

t Hart L, Lemkes H, Heine R, Stolk R, Feskens E, Jansen J . Prevalence of maternally inherited diabetes and deafness in diabetic populations in The Netherlands. Diabetologia. 1994; 37(11):1169-70. DOI: 10.1007/BF00418385. View

20.

Ciafaloni E, Ricci E, Servidei S, Shanske S, Silvestri G, Manfredi G . Widespread tissue distribution of a tRNALeu(UUR) mutation in the mitochondrial DNA of a patient with MELAS syndrome. Neurology. 1991; 41(10):1663-4. DOI: 10.1212/wnl.41.10.1663. View